stella
beta
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease — Stella
Recruiting
Back to Chronic Kidney Diseases trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Northwestern University, Chicago, Illinois
View full record on ClinicalTrials.gov